Literature DB >> 12941859

Kawasaki syndrome hospitalizations and associated costs in the United States.

Ermias D Belay1, Robert C Holman, Ryan A Maddox, David A Foster, Lawrence B Schonberger.   

Abstract

OBJECTIVES: To describe the epidemiologic characteristics of patients hospitalized with Kawasaki syndrome (KS) and estimate associated costs in the United States, using a large national hospital discharge dataset.
METHODS: Hospitalization discharge records with KS for 1997 through 1999 for U.S. residents <18 years of age were selected from Solucient's hospital discharge records. These records are collected from most of the self-governing children's hospitals and approximately one-third of short-term, non-federal general hospitals in the United States.
RESULTS: A total of 7,431 hospital discharges with a KS diagnosis were identified; 2,270 of the discharges were in 1997, 2,700 in 1998, and 2,461 in 1999. Boys comprised 60.0% of the discharges, and 76.4% of discharges were among children ages <5 years. For the 44 states and the District of Columbia with at least one hospital reporting KS, the average annual KS hospitalization rate was 10.2 per 100,000 children ages <5 years. The KS hospitalization rate for boys (12.0 per 100,000) was higher than that for girls (8.3 per 100,000) (risk ratio 1.45; 95% confidence interval 1.37, 1.52). Extrapolation to the U.S. population showed an estimated average annual KS hospitalization rate of 21.6. The median KS hospitalization cost for children <5 years of age during the study period was $6,169 US dollars.
CONCLUSIONS: The KS hospitalization rate was consistent with that of previous U.S. studies, although the extrapolated rate may be an overestimation. The median hospitalization cost for KS was higher than that for respiratory syncytial virus-associated bronchiolitis and diarrheal diseases. Large hospitalization datasets can be used to monitor the occurrence of KS in the United States.

Entities:  

Mesh:

Year:  2003        PMID: 12941859      PMCID: PMC1497579          DOI: 10.1093/phr/118.5.464

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  14 in total

1.  Cardiovascular procedures in patients with mental disorders.

Authors:  J K Young; D A Foster
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

2.  Epidemiology of Reye's syndrome, United States, 1991-1994: comparison of CDC surveillance and hospital admission data.

Authors:  K M Sullivan; E D Belay; R E Durbin; D A Foster; D F Nordenberg
Journal:  Neuroepidemiology       Date:  2000 Nov-Dec       Impact factor: 3.282

3.  Kawasaki syndrome among American Indian and Alaska Native children, 1980 through 1995.

Authors:  R C Holman; E D Belay; M J Clarke; S F Kaufman; L B Schonberger
Journal:  Pediatr Infect Dis J       Date:  1999-05       Impact factor: 2.129

4.  Kawasaki syndrome hospitalizations among children in the United States, 1988-1997.

Authors:  Robert C Holman; Ermias D Belay; Aaron T Curns; Lawrence B Schonberger; Claudia Steiner
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

5.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

6.  Kawasaki syndrome hospitalizations among children in Hawaii and Connecticut.

Authors:  R C Holman; A Shahriari; P V Effler; E D Belay; L B Schonberger
Journal:  Arch Pediatr Adolesc Med       Date:  2000-08

7.  The incidence of Kawasaki syndrome in West Coast health maintenance organizations.

Authors:  E D Belay; R C Holman; M J Clarke; F Destefano; A Shahriari; R L Davis; P H Rhodes; R S Thompson; S B Black; H R Shinefield; S M Marcy; J I Ward; J P Mullooly; R T Chen; L B Schonberger
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

8.  Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan.

Authors:  H Yanagawa; Y Nakamura; M Yashiro; T Ojima; S Tanihara; I Oki; T Zhang
Journal:  Pediatrics       Date:  1998-12       Impact factor: 7.124

9.  Kawasaki syndrome in Washington State. Race-specific incidence rates and residential proximity to water.

Authors:  R L Davis; P L Waller; B A Mueller; C A Dykewicz; L B Schonberger
Journal:  Arch Pediatr Adolesc Med       Date:  1995-01

Review 10.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  5 in total

1.  Simulation based planning of surgical interventions in pediatric cardiology.

Authors:  Alison L Marsden
Journal:  Phys Fluids (1994)       Date:  2013-10-23       Impact factor: 3.521

2.  Health care utilization and costs following Kawasaki disease.

Authors:  Cal Robinson; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Hsien Seow; Michelle Batthish
Journal:  Paediatr Child Health       Date:  2022-03-01       Impact factor: 2.600

3.  Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease.

Authors:  Preeti Jaggi; Asuncion Mejias; Zhaohui Xu; Han Yin; Melissa Moore-Clingenpeel; Bennett Smith; Jane C Burns; Adriana H Tremoulet; Alejandro Jordan-Villegas; Damien Chaussabel; Karen Texter; Virginia Pascual; Octavio Ramilo
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

Review 4.  Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Authors:  Pablo A González; Leandro J Carreño; Pablo F Céspedes; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Clin Dev Immunol       Date:  2013-03-07

5.  Viral infections associated with Kawasaki disease.

Authors:  Luan-Yin Chang; Chun-Yi Lu; Pei-Lan Shao; Ping-Ing Lee; Ming-Tai Lin; Tsui-Yien Fan; Ai-Ling Cheng; Wan-Ling Lee; Jen-Jan Hu; Shu-Jen Yeh; Chien-Chih Chang; Bor-Luen Chiang; Mei-Hwan Wu; Li-Min Huang
Journal:  J Formos Med Assoc       Date:  2014-02-01       Impact factor: 3.282

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.